A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)

NCT01075282 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

810

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Insulin Glargine
DRUG: LY2189265
DRUG: Metformin
DRUG: Glimepiride

Sponsor

Eli Lilly and Company